Scholars Central

Conference abstractPublished 15 Aug 2011

Mechanical blocking of cancer cell division by progerin

Authors: Olga Moiseeva

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The nuclear lamina is a fibrous structure underneath the inner nuclear membrane. One of the main components of lamina is the intermediate filament protein lamin A. Different lamin A mutations lead to development of a wide range of diseases, termed laminopathies. The most severe laminopathy is Hutchinson-Gilford progeria syndrome (progeria), which is characterized by premature aging, but not accompanied by an increase in cancer incidence. Progerin is a lamin A mutant with 50-aa deletion near the C-terminus. The inhibition of cancer cell proliferation by progerin is a consequence of accumulation of polymeric progerin formations in lamina that physically blocks mitosis. Based on our results with progerin, we propose to use a mechanical approach in cancer therapy. Such an approach might work despite the mutations present in cancer cells, and therefore can be also effective at the late stages of cancer development. The disadvantage of the mechanical approach is that this approach could be toxic for normal dividing cells. To decrease the toxicity, targeted therapy can be used. Theoretically, this mechanical approach does not have to be limited to the nuclear lamina since different targets can be physically blocked inside and outside the cells. For example, a stable polymeric cage could be created around cancer cells to provide a physical barrier to proliferation that could act independently of any mutations. Any or several specific cancer receptors can be used, including those promoting proliferation. A wide range of polymeric nanoparticles is now available, magnetic nanoparticles can also be used.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Olga Moiseeva”